Differences between the 2 groups were observed in 5 markers, namely, G-CSF, IL-1RA, IL-6, IL-21, and mean platelet volume, all of them higher in patients with PAP/SAPIPO > 0.40 (Table 5). This evidence concerns the gene CSF3 and pulmonary alveolar proteinosis.